In humans, increased levels of oxidized low-density lipoprotein (ox-LDL) have been associated with a high incidence of metabolic syndrome, acute coronary events, hepatocellular injury, and fibrosis mediated by lectin-like oxidized LDL receptor 1 (Lox-1) [4,5]. The gene discussed is OLR1; the disease is metabolic syndrome.